These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31653275)

  • 1. A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation.
    Paquette M; Alotaibi AM; Nieuwlaat R; Santesso N; Mbuagbaw L
    Syst Rev; 2019 Oct; 8(1):241. PubMed ID: 31653275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of anticoagulants in patients with atrial fibrillation and history of falls or risk of falls: protocol for a systematic review and meta-analysis.
    Galvain T; Hill R; Donegan S; Lisboa P; Lip GYH; Czanner G
    Syst Rev; 2022 Apr; 11(1):63. PubMed ID: 35395931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials.
    Cope S; Clemens A; Hammès F; Noack H; Jansen JP
    Value Health; 2015 Mar; 18(2):234-49. PubMed ID: 25773559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.
    Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA;
    Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study.
    Liu P; Ioannidis JPA; Ross JS; Dhruva SS; Luxkaranayagam AT; Vasiliou V; Wallach JD
    BMC Med; 2019 Oct; 17(1):188. PubMed ID: 31639007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Atrial Fibrillation: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Kahwati LC; Asher GN; Kadro ZO; Keen S; Ali R; Coker-Schwimmer E; Jonas DE
    JAMA; 2022 Jan; 327(4):368-383. PubMed ID: 35076660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis.
    Su X; Yan B; Wang L; Lv J; Cheng H; Chen Y
    Am J Kidney Dis; 2021 Nov; 78(5):678-689.e1. PubMed ID: 33872690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
    Ruff CT; Giugliano RP; Braunwald E; Hoffman EB; Deenadayalu N; Ezekowitz MD; Camm AJ; Weitz JI; Lewis BS; Parkhomenko A; Yamashita T; Antman EM
    Lancet; 2014 Mar; 383(9921):955-62. PubMed ID: 24315724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of digoxin on mortality in patients with atrial fibrillation: Overview of systematic reviews.
    Baker WL; Sobieraj DM; DiDomenico RJ
    Pharmacotherapy; 2021 Apr; 41(4):394-404. PubMed ID: 33544894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.
    Clarkesmith DE; Pattison HM; Khaing PH; Lane DA
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD008600. PubMed ID: 28378924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.
    Page MJ; McKenzie JE; Kirkham J; Dwan K; Kramer S; Green S; Forbes A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):MR000035. PubMed ID: 25271098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions and Strategies to Improve Oral Anticoagulant Use in Patients with Atrial Fibrillation: A Systematic Review of Systematic Reviews.
    Ng SS; Lai NM; Nathisuwan S; Chaiyakunapruk N
    Clin Drug Investig; 2018 Jul; 38(7):579-591. PubMed ID: 29569095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
    Kimachi M; Furukawa TA; Kimachi K; Goto Y; Fukuma S; Fukuhara S
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011373. PubMed ID: 29105079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.
    Aguilar MI; Hart R; Pearce LA
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006186. PubMed ID: 17636831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic screening for the detection of atrial fibrillation.
    Moran PS; Teljeur C; Ryan M; Smith SM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009586. PubMed ID: 27258214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
    Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
    Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
    Aguilar MI; Hart R
    Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD001927. PubMed ID: 16034869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis.
    Kishore A; Vail A; Majid A; Dawson J; Lees KR; Tyrrell PJ; Smith CJ
    Stroke; 2014 Feb; 45(2):520-6. PubMed ID: 24385275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.